VRAYQ vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, APLMW, and ARTLW
Should you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), Apollomics (APLMW), and Artelo Biosciences (ARTLW). These companies are all part of the "medical" sector.
180 Life Sciences (NASDAQ:ATNFW) and ViewRay (NASDAQ:VRAYQ) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk.
180 Life Sciences has higher earnings, but lower revenue than ViewRay.
In the previous week, 180 Life Sciences had 2 more articles in the media than ViewRay. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for ViewRay. ViewRay's average media sentiment score of 1.88 beat 180 Life Sciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.
180 Life Sciences and ViewRay both received 0 outperform votes by MarketBeat users.
15.5% of ViewRay shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
ViewRay beats 180 Life Sciences on 3 of the 5 factors compared between the two stocks.
Get ViewRay News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VRAYQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VRAYQ vs. The Competition
Related Companies and Tools
